DOI work
Fetched
Post
crossref
Reshma Ramachandran, Christopher J. Morten, Joseph S. Ross
(2021).
Strengthening the FDA’s Enforcement of ClinicalTrials.gov Reporting Requirements.
JAMA, 326(21), 2131.
American Medical Association (AMA).
- Publication date
-
7 Dec 2021
- Identifier
-
10.1001/jama.2021.19773
- Authors
-
Reshma Ramachandran,
Christopher J. Morten,
Joseph S. Ross
- Source
- JAMA
- Details
- 326(21), 2131
- Reference type
- article
- Publisher
- American Medical Association (AMA)
- Metadata source
- crossref
Abstract
This Viewpoint discusses ways in which the FDA could harness its enforcement tools to bring important missing clinical trial results information to light and demonstrate its commitment to protecting patients through clinical trial transparency.
Study authors in this cited reference